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Abstract Liver development is regulated by soluble factors as
well as cell^cell contacts. We previously reported that oncostatin
M (OSM) induced hepatic maturation in a primary culture of
embryonic day 14 liver cells. While OSM expression in the liver
starts in mid gestation and decreases in postnatal stages,
hepatocyte growth factor (HGF) is mainly expressed in the liver
in the first few days after birth. In this study, we compared the
effect of OSM and HGF on the differentiation of fetal hepatic
cells in vitro. Like OSM, HGF in the presence of dexamethasone
induced expression of glucose-6-phosphatase, tyrosine amino
transferase and carbamoyl-phosphate synthase, and accumula-
tion of glycogen in fetal hepatic cells, although to a lesser extent
than OSM. Interestingly, while both OSM and HGF up-
regulated production of albumin, secretion of albumin occurred
only in response to OSM. In addition, although hepatic
maturation induced by OSM depends on STAT3, HGF failed
to activate STAT3 and HGF-induced differentiation was
independent of STAT3. These results indicate that OSM and
HGF induce hepatic maturation through different signaling
pathways. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Adult liver is a central organ for metabolism and maintains
homeostasis, whereas fetal liver has little metabolic function
[1^3]. Instead, it functions as the major hematopoietic organ
in mid- to late fetus [4]. During the late-fetal stage, the hem-
atopoietic site shifts to the spleen and bone marrow and con-
comitantly hepatocytes acquire various functions of the ma-
ture liver. We previously described that hematopoietic cells in
mid-fetal livers produce oncostatin M (OSM), an interleukin
(IL)-6 family cytokine (reviewed in [5]), and that OSM induces
maturation of fetal hepatic cells derived from the embryonic
day 14.5 (E14.5) liver in vitro; such as expression of glucose-
6-phosphatase (G6Pase) and tyrosine amino transferase
(TAT) and accumulation of glycogen [6,7]. Consistent with
those in vitro results, the levels of TAT as well as glycogen
accumulation were signi¢cantly reduced in the liver derived
from knockout mice of gp130, the common receptor subunit
of IL-6 family cytokines [6,8]. However, the level of TAT
expression induced by OSM was lower than in adult liver
and an adult hepatocyte marker tryptophan oxygenase was
not induced in vitro by OSM, suggesting that OSM allows
the E14.5 fetal hepatocytes to acquire the characteristics of
the neonatal liver. The expression level of TAT in vivo is
further up-regulated during postnatal development, while ex-
pression of OSM in the liver decreases during late-fetal and
neonatal stages since the major hematopoietic activity shifts to
the spleen and bone marrow at these stages. Therefore, an-
other factor may be involved in the liver maturation process.
Hepatocyte growth factor (HGF) was originally identi¢ed
in serum of partially hepatectomized rats and rat platelets and
was shown to directly stimulate proliferation of adult hepato-
cytes in vitro (reviewed in [9]). In addition, HGF mRNA was
remarkably increased when hepatic injury was induced by
hepatotoxins (CCl4 and D-galactosamine) in rats [10,11].
These ¢ndings indicate that HGF is an important factor for
liver regeneration. It was previously described that mRNAs
for HGF and c-Met (the receptor of HGF) were increased at
a postnatal stage in several rat tissues such as the liver, lung
and kidney [12], suggesting that HGF is involved in the devel-
opment of these organs.
In this study, we investigated whether HGF is involved in
the neonatal hepatic cell di¡erentiation after expression of
OSM in the liver is down-regulated. We show that HGF in-
duces expression of liver di¡erentiation marker genes and gly-
cogen accumulation. Analysis of intracellular signals demon-
strates that HGF does not activate signal transducer and
activator of transcription 3 (STAT3) in fetal hepatic cells
and the HGF-induced hepatic di¡erentiation is not inhibited
by dominant negative STAT3 (vSTAT3), indicating that
OSM and HGF induce liver development through di¡erent
signaling pathways.
2. Materials and methods
2.1. Materials
C57BL/6CrSlc mice (Nihon SLC, Sizuoka, Japan) were used in all
experiments in this study. Dulbecco’s modi¢ed Eagle’s medium
(DMEM), fetal calf serum (FCS), liver perfusion medium, liver digest
medium, MEM non-essential amino acid solution and insulin^trans-
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ferrin^selenium X (ITS) were purchased from Gibco-BRL. Human
HGF was from Becton Dickinson. Murine OSM was from RpD
Systems. Anti-mouse albumin antibody was purchased from Nordic
Immunological Laboratories. Antibodies against murine phospho-
STAT3, phospho-ERK1/2 and ERK1/2 were purchased from New
England Biolabs. Anti-STAT3 antibody was from Transduction
Lab.
2.2. Reverse transcription (RT)-PCR analysis
Total RNA was extracted from livers derived from E14, E18, neo-
natal, 10-day-old and adult mice by the acid guanidinium^phenol^
chloroform (AGPC) method [13]. First-strand cDNA was synthesized
from 1 Wg of total RNA using the First-Strand cDNA Synthesis kit
(Amersham-Pharmacia) and was used as a template for PCR ampli-
¢cation with murine HGF primers (forward primer: 5P-AGA-CAC-
CAC-ACC-GGC-ACA-AGT, reverse primer: 5P-ATA-GGG-CAA-
TAA-TCC-CAA-GG) or murine OSM primers [14]. The primers
were annealed at 50‡C for 60 s and ampli¢cation was repeated for
30V40 cycles. Ampli¢ed products were separated by electrophoresis
on a 1.5% agarose gel and stained with ethidium bromide.
2.3. Cell culture
Fetal hepatic culture derived from E14 mouse livers was previously
described [6]. Brie£y, eight or nine embryonic liver tissues were
minced and dissociated with liver digest medium followed by hemol-
ysis with hypotonic bu¡er. Cells were cultured in DMEM supple-
mented with 10% FCS, 2 mM L-glutamine, 1U non-essential amino
acid solution, 1U ITS, 50 Wg/ml gentamicin and 1037 M dexametha-
sone (Dex) onto 0.1% gelatin-coated tissue culture dishes. Several
hours later, these cells were washed with culture media to remove
contaminating hematopoietic cells and cell debris. Culture media
were replaced every 2 days. Each experiment described in the paper
was repeated at least twice and typical results are shown in ¢gures.
2.4. Periodic acid-Shi¡ (PAS) staining
Fetal hepatic cells were cultured in the presence of 10 ng/ml OSM
or 20 ng/ml HGF for 6 days. Cells were ¢xed with 20% formaldehyde.
Intercellular glycogen was stained with the PAS staining solution
(Muto Pure Chem., Japan) according to the standard protocol.
2.5. Northern blot analysis
Cellular and tissue total RNA samples were extracted by the AGPC
method. 10 Wg total RNA from each sample was separated by elec-
trophoresis on a 1.5% agarose gel containing 2% formaldehyde. RNA
was transferred to a positively charged Nylon membrane (Boehringer-
Mannheim) and was hybridized with digoxigenin (DIG)-labeled
cDNA probes generated by the rTaq DNA polymerase reaction.
The membrane was then incubated with an alkaline phosphatase-la-
beled anti-DIG antibody (Boehringer-Mannheim) and developed with
the CDP-star reagent (New England Biolabs).
2.6. Western blot analysis
Cells were washed with phosphate-bu¡ered saline and lysed with
lysis bu¡er (150 mM NaCl, 1.0% NP-40, 50 mM Tris^HCl (pH 8.0),
1 mM phenylmethylsulfonyl £uoride, 1 Wg/ml leupeptin, 1 mM sodium
vanadate and 1 mM EDTA). The protein lysates were mixed with
sodium dodecyl sulfate (SDS) sample loading bu¡er containing L-mer-
captoethanol, electrophoresed on an 8 or 10% SDS^polyacrylamide
gel (SDS^PAGE) and electrotransferred onto an Immobilon-P mem-
brane (Millipore). Membranes were blocked with Tris-bu¡ered saline
with Tween 20 (TBS-Tween; 20 mM Tris^HCl, 150 mM NaCl, 0.1%
Tween 20) containing 3% bovine serum albumin and incubated with a
primary antibody in TBS-Tween. Membranes were washed with TBS-
Tween and incubated with a horseradish peroxidase-conjugated sec-
ondary antibody (Amersham-Pharmacia). After another wash with
TBS-Tween, immunoreactive proteins were developed by the ECL
reagent (Amersham-Pharmacia) and blots were exposed to a Bio-
Max ¢lm (Kodak).
2.7. Detection of albumin secretion
Fetal hepatic cells (4U106) were inoculated in 60-mm dishes and
incubated with either 10 ng/ml OSM or 20 ng/ml HGF for 6 days. The
culture medium was changed to serum-free medium and incubated for
48 h. Culture supernatants were collected and the amount of secreted
albumin was measured by the bromocresol green (BCG) method [15].
The rate of albumin secretion per cell was determined by dividing the
total amount of secreted albumin by the number of cells in the cul-
ture.
2.8. Retrovirus-mediated gene transfer
Retrovirus carrying the cDNA for vSTAT3 [16] was produced us-
ing the packaging cell line BOSC23, and was infected to fetal hepatic
cells as described previously [17]. Brie£y, 3 Wg of the retrovirus DNA
constructs was transfected into BOSC23 cells (2U106 cells grown in a
60-mm tissue culture dish) using the Lipofectamine-plus reagent (Gib-
co-BRL) according to the manufacturer’s instructions. Two days after
transfection, the supernatant containing viral particles was collected.
Freshly isolated fetal hepatic cells (4U105 cells in a 35-mm culture
dish) were incubated with 1.5 ml of the supernatant solution in the
presence of 1U1036 M Dex and 1U ITS for 12 h. Then, the culture
medium was changed to virus-free growth medium.
3. Results
3.1. Expression of HGF and OSM during liver development
We previously demonstrated that OSM induces maturation
of fetal hepatic cells in vitro [6]. However, as OSM is ex-
pressed in the mid-fetal to perinatal liver and its expression
level is signi¢cantly decreased after birth, another factor may
be involved in hepatic maturation. It was reported that HGF
and c-Met are mainly expressed in the ¢rst few days after
birth in rat livers [12]. We therefore examined whether expres-
sion of HGF in mouse livers is also detected during postnatal
stages. Total RNA isolated from E14, E18, neonatal, 10-day-
old and adult livers was used to detect HGF and OSM
mRNA by the semi-quantitative PCR method. Fig. 1 shows
that OSM mRNA was expressed during mid- to late-fetal
stages and decreased after birth. In contrast, the HGF level
was signi¢cantly increased at the perinatal stage and reached a
maximum several days after birth.
3.2. Induction of hepatic maturation by HGF and OSM
We next examined the e¡ects of HGF on gene expression in
primary culture of E14 fetal hepatic cells (Fig. 2A). Cells were
cultured for 7 days in the presence or absence of 10 ng/ml
OSM or 20 ng/ml HGF and mRNAs for liver di¡erentiation
Fig. 1. Developmental changes of OSM and HGF expression. First-
strand cDNAs were synthesized from murine liver tissues derived
from E14, E18, neonatal, 10-day-old and adult mice. Synthesized
cDNA samples were used as templates for RT-PCR analyses of
OSM, HGF and hypoxanthine guanine phospho-ribosyltransferase
(HPRT as an internal control) mRNAs during liver development.
HGF mRNA was signi¢cantly increased for several days after birth.
In contrast, expression of OSM was down-regulated in the postnatal
liver.
FEBS 24590 5-3-01 Cyaan Magenta Geel Zwart
A. Kamiya et al./FEBS Letters 492 (2001) 90^94 91
marker genes were detected by Northern blotting. Expression
of G6Pase, TAT and carbamoyl-phosphate synthase (CPS)
was signi¢cantly induced by HGF in combination with
1U1037 M Dex, suggesting that HGF is capable of inducing
liver maturation in vitro. Dex was strictly required for the
induction of hepatic di¡erentiation markers by HGF since
no mRNAs of these genes were detected in the absence of
Dex.
In our previous work, we showed that OSM is able to
induce glycogen accumulation, one feature of adult liver
[18], in fetal hepatic cells. We investigated glyconeogenesis
in culture stimulated by HGF. Fetal hepatic cells were cul-
tured for 6 days either with OSM or with HGF and the intra-
cellular glycogen accumulation was analyzed by staining the
cells with the PAS reagent. A slight accumulation of glycogen
was detected in the presence of Dex alone (Fig. 2B) and this
was signi¢cantly increased by OSM and HGF (Fig. 2C,D).
Since no accumulation of glycogen was induced by HGF
alone in the absence of Dex, induction of glycogenesis strictly
requires glucocorticoid (data not shown).
3.3. Production and secretion of albumin by HGF and OSM
Serum albumin is the most abundant protein synthesized by
Fig. 2. Induction of hepatic maturation by HGF. (A) Induction of
G6Pase, TAT and CPS requires OSM or HGF in combination with
Dex. Fetal hepatic cells were cultured for 7 days, and expression of
hepatic genes and GAPDH (internal control) was analyzed using
DIG-labeled cDNA probes. (B^D) Glyconeogenesis in cultured he-
patocytes induced by OSM and HGF. Fetal hepatic cells derived
from E14 embryonic livers were cultured for 6 days in the absence
(B) or presence of OSM (C) or HGF (D) in combination with 1037
M Dex. Fetal hepatocytes cultured with Dex alone accumulated a
limited amount of glycogen. In contrast, a number of PAS-positive
cells appeared when cultured with either OSM or HGF in the pres-
ence of Dex for 6 days. Fig. 3. Di¡erential regulation of albumin production and secretion
by OSM and HGF. (A) E14 hepatic cells were cultured for 7 days
in the presence of OSM and HGF in combination with Dex. Cells
were lysed in NP-40 lysis bu¡er and albumin was detected by West-
ern blotting. OSM and HGF signi¢cantly induced albumin produc-
tion. (B) Hepatocytes were cultured for 6 days in the presence of
OSM and HGF, and culture media were changed to serum-free me-
dia. After 48 h, secreted albumin in media was detected by the
BCG method. Albumin secretion was induced by OSM but not
HGF. Columns, amount of secreted albumin in media relative to
control. The amount of albumin secreted in the presence of OSM
sets to 1.0. Values and vertical bars are each indicated as the mean
and S.D. of triplicate experiments, respectively.
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hepatocytes and its production starts in the early stage of liver
development and reaches the maximum level in the adult liver
[19]. We measured the intracellular content of albumin to
examine the e¡ect of HGF on albumin production in fetal
hepatic culture. After 7 days of incubation with or without
HGF, equal amounts of total cellular proteins were used for
Western blotting. The albumin levels were increased when
fetal hepatic cells were cultured with either OSM or HGF
(Fig. 3A). These results were consistent with a previous report
that HGF in combination with Dex induced albumin produc-
tion in rat fetal and adult hepatocytes [20]. Interestingly, how-
ever, secretion of albumin into the culture medium was in-
duced only by OSM and not by HGF (Fig. 3B). These
results indicate that OSM and HGF activate distinct sets of
signaling molecules and that secretion of albumin depends on
the pathway speci¢cally stimulated by OSM.
3.4. STAT3 is activated by OSM but not by HGF in fetal
hepatic cells
Previously, we described that gp130 is essential for OSM-
induced hepatic di¡erentiation [6]. STAT3 is a latent tran-
scription factor that is activated by IL-6 family cytokines
through gp130 [21,22]. Recently, we found that STAT3 plays
a major role in the OSM-induced di¡erentiation of fetal he-
patic cells [23]. We investigated whether or not STAT3 is
involved in the induction by HGF of the hepatic di¡erentia-
tion markers in our culture system. Fetal hepatocytes were
cultured for 5 days in the presence or absence of either 10
ng/ml OSM or 20 ng/ml HGF in combination with Dex (Fig.
4A). Phosphorylation of STAT3 was detected in the cells cul-
tured with OSM but not HGF. Furthermore, phosphorylation
of STAT3 was rapidly induced by OSM in 5 or 15 min,
whereas HGF failed to induce it. While it was previously
reported that the STAT3 activation by HGF was observed
after a long latency [24], no phosphorylation of STAT3 was
detected even after 7 h of HGF stimulation in our culture
(data not shown). The inability of HGF to phosphorylate
STAT3 was not due to the lack of receptor activation, since
ERK, another signaling molecule activated by these factors,
was signi¢cantly phosphorylated under the same conditions
(Fig. 4B).
3.5. HGF induced hepatic maturation through
STAT3-independent signaling pathways
To further examine the role of STAT3 in HGF-induced
di¡erentiation, vSTAT3, a dominant negative form of
STAT3, was expressed in primary fetal hepatic culture using
the retroviral gene delivery system [23]. As a control, we also
infected the cells with the vector pMX-IRES-GFP [25]. Fetal
hepatic cells were cultured in the presence of OSM or HGF
for 6 days and expression of TAT was analyzed by Northern
blotting (Fig. 5). Expression of vSTAT3 resulted in inhibition
of OSM-induced expression of TAT. In contrast, it failed to
inhibit HGF-induced expression of TAT. These results indi-
cate that activation of STAT3 is responsible for the hepatic
di¡erentiation regulated by OSM, while HGF-induced matu-
ration is mediated by STAT3-independent pathways.
4. Discussion
In this report, we showed that HGF, in addition to OSM,
has the ability to induce hepatic maturation as evidenced by
expression of hepatic di¡erentiation marker genes and glyco-
gen accumulation. Interestingly, HGF was not able to induce
the phosphorylation of STAT3 that is required for OSM-in-
duced hepatic maturation and vSTAT3 blocked hepatic dif-
ferentiation induced by OSM but not HGF, indicating that
OSM and HGF induce hepatic maturation via distinct signal
molecules. As OSM induces higher levels of expression of liver
di¡erentiation marker genes and of glycogen accumulation
than HGF, it may play a more active role in the maturation
of hepatic cells at these stages.
Liver development is known to proceed through several
distinct steps and it seems that di¡erent key soluble factors
are involved in each process. In mice, the initial event in liver
Fig. 4. Activation of STAT3 and ERK1/2 induced by OSM and
HGF. (A) Fetal hepatocytes were cultured for 5 days in the absence
or presence of OSM or HGF in combination with Dex. Phosphory-
lation of STAT3 was detected only in the culture with OSM. Fur-
thermore, fetal hepatocytes were cultured for 5 days with Dex alone
and were then stimulated by either OSM or HGF for 5 or 15 min.
(B) Consistent with previous results, OSM and HGF induced phos-
phorylation of ERK1/2 equally, while phosphorylation of STAT3
was only detectable in the OSM-stimulated cells.
Fig. 5. Hepatic maturation induced by HGF is independent of
STAT3. E14 fetal hepatic cells were infected with the retrovirus vec-
tors, pMX (mock) and pMX-vSTAT3 (dominant negative STAT3).
The cells were cultured for 7 days in the presence of OSM or HGF,
and TAT mRNA levels were determined by Northern blotting. Ex-
pression of TAT induced by OSM was signi¢cantly reduced by the
infection with pMX-vSTAT3 while HGF-induced TAT mRNA ex-
pression was una¡ected.
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development occurs at E9. The foregut endoderm commits to
become the liver through interaction with the cardiogenic
mesoderm [26,27]. Recent study shows that ¢broblast growth
factors 1 and 2 produced by mesodermal cells are involved in
hepatic di¡erentiation in this step [28]. In contrast, we previ-
ously reported that OSM is a paracrine factor produced by
hematopoietic cells and plays an important role in hepatic
maturation during the mid- to late-fetal stages [6]. These re-
sults suggest that liver development is controlled by several
distinct paracrine factors. Expression of OSM gradually de-
creases during late-fetal and neonatal stages (Fig. 1). In con-
trast, expression of TAT is increased after birth, therefore,
another factor might be involved in postnatal liver develop-
ment. HGF is signi¢cantly expressed after birth in the liver
and induces maturation of fetal hepatic cells (Figs. 1 and 2).
During late-fetal to neonatal development, hematopoietic cells
relocate to the spleen and bone marrow, and non-parenchy-
mal cells (e.g. sinusoidal endothelial cells and stellate cells)
increase in the liver. As HGF is produced by non-parenchy-
mal cells during liver regeneration [29,30], the increase of
HGF expression in the postnatal liver is correlated with the
proliferation of non-parenchymal cells. Thus, HGF seems to
be a paracrine factor that is involved in the postnatal hepatic
maturation.
Although both OSM and HGF induced hepatic di¡erentia-
tion in the presence of Dex, their signaling mechanisms are
quite di¡erent. A notable di¡erence between OSM and HGF
was their capability to activate STAT3. Hepatic maturation
induced by OSM is mediated through STAT3 since expression
of hepatic di¡erentiation markers was e⁄ciently inhibited by
expression of vSTAT3 in fetal hepatic culture [23]. In sharp
contrast, HGF did not activate STAT3 in fetal hepatic cells
and expression of vSTAT3 failed to inhibit expression of the
liver di¡erentiation marker gene induced by HGF (Figs. 4A
and 5). It is currently unknown what signaling molecules are
responsible for HGF-mediated hepatic di¡erentiation. How-
ever, gp130 knockout mice exhibit severe defects in hepatic
maturation but the expression of TAT and accumulation of
glycogen are not totally abrogated in these mice, suggesting
that OSM- and STAT3-independent signaling pathways are
involved in the in vivo liver development. It is, therefore,
possible that the signal molecules activated by HGF partly
substitute for the functions of OSM in liver development of
gp130 knockout mice. In addition, we recently found that
fetal hepatic cells di¡erentiate in the absence of OSM in a
high cell density culture and di¡erentiation under these con-
ditions is STAT3-independent [15]. Taken together, there ap-
pears to be an alternative signaling pathway for hepatic mat-
uration and it would be interesting to identify the signaling
molecules involved in hepatic maturation induced by HGF
and/or high cell density culture.
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